Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

19
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

34
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
34
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

26
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
Autoimmune Disorders01:29

Autoimmune Disorders

601
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
601
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

35
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and risk factors of hyperuricemia and gout in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Frontiers in endocrinology·2026
Same author

Sex-specific dysregulation of sex hormones by heavy metal mixtures: Multi-model analysis identifies cadmium as the primary driver.

Ecotoxicology and environmental safety·2026
Same author

The mediating role of self-efficacy between time management disposition and deep learning ability among undergraduate nursing students: A cross-sectional study.

Nurse education today·2026
Same author

Investigating the Therapeutic Effect and Mechanism of Astragalus Mongholicus on Graves' Disease through Network Pharmacology.

Current pharmaceutical design·2026
Same author

Beyond pathogens: a narrative review of the immunological nexus of damage-associated molecular patterns and inflammasome activation in sterile AECOPD.

Frontiers in immunology·2026
Same author

Chinese herbal formulas as adjuncts to antihistamines in chronic spontaneous urticaria: a network meta-analysis of efficacy, recurrence, and safety.

Frontiers in pharmacology·2026

Related Experiment Video

Updated: Aug 15, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

475

Immunity: Psoriasis comorbid with atherosclerosis.

Chunping Liu1,2,3,4, Huiqi Chen1,3, Yanjiao Liu1,3

  • 1State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affilliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

Frontiers in Immunology
|January 2, 2023
PubMed
Summary
This summary is machine-generated.

Psoriasis, an immune-mediated disease, shares systemic inflammation with atherosclerosis (AS). This study explores the epidemiological and immune links between psoriasis and AS comorbidities to guide future research.

Keywords:
atherosclerosiscomorbidityimmunologyinflammationpsoriasis

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.2K
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

14.7K

Related Experiment Videos

Last Updated: Aug 15, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

475
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.2K
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

14.7K

Area of Science:

  • Immunology
  • Dermatology
  • Cardiovascular Medicine

Background:

  • Psoriasis is a chronic, immune-mediated inflammatory disease with genetic factors.
  • Systemic inflammation is implicated in psoriasis, which can affect multiple organs.
  • Atherosclerosis (AS) is a frequent comorbidity in patients with severe or prolonged psoriasis.

Purpose of the Study:

  • To investigate the potential epidemiological relationship between psoriasis and atherosclerotic comorbidities.
  • To explore the underlying immune mechanisms linking psoriasis and atherosclerosis.
  • To provide a basis for future scientific research on this association.

Main Methods:

  • Review of existing epidemiological data on psoriasis and AS.
  • Analysis of immune pathways involved in both conditions.
  • Exploration of shared inflammatory mediators and cellular processes.

Main Results:

  • Psoriasis and AS share common features of systemic inflammation.
  • Immune cell activation and pro-inflammatory factors are crucial in the progression of both diseases.
  • A strong association exists between psoriasis and atherosclerotic comorbidities.

Conclusions:

  • Systemic inflammation is a potential common link between psoriasis and atherosclerosis.
  • Understanding these links can inform clinical management and research strategies.
  • Further investigation into the epidemiological and immunological aspects is warranted.